Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber… - European journal of …, 2017 - Springer
Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
PSMA-targeted radiopharmaceuticals for imaging and therapy
HJ Wester, M Schottelius - Seminars in nuclear medicine, 2019 - Elsevier
As described in more detail in other contributions in this issue of Seminars in Nuclear
Medicine, prostate-specific membrane antigen (PSMA) has become one of the most …
Medicine, prostate-specific membrane antigen (PSMA) has become one of the most …
NCCN guidelines® insights: prostate cancer, version 1.2023: featured updates to the NCCN guidelines
EM Schaeffer, S Srinivas, N Adra, Y An… - Journal of the National …, 2022 - jnccn.org
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a
prostate cancer diagnosis and include management options for localized, regional …
prostate cancer diagnosis and include management options for localized, regional …
Matched-pair comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical …
I Rauscher, M Krönke, M König, A Gafita… - Journal of nuclear …, 2020 - Soc Nuclear Med
18F-labeled prostate-specific membrane antigen (PSMA)–ligand PET has several principal
advantages over 68Ga-PSMA-11. The purpose of this retrospective study was to evaluate …
advantages over 68Ga-PSMA-11. The purpose of this retrospective study was to evaluate …
Appropriate use criteria for prostate-specific membrane antigen PET imaging
Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
Optimum imaging strategies for advanced prostate cancer: ASCO guideline
PURPOSE Provide evidence-and expert-based recommendations for optimal use of
imaging in advanced prostate cancer. Due to increases in research and utilization of novel …
imaging in advanced prostate cancer. Due to increases in research and utilization of novel …
[HTML][HTML] 18F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging
RA Werner, T Derlin, C Lapa, S Sheikbahaei… - Theranostics, 2020 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA)-targeted PET imaging for prostate cancer with
68 Ga-labeled compounds has rapidly become adopted as part of routine clinical care in …
68 Ga-labeled compounds has rapidly become adopted as part of routine clinical care in …
A systematic review on the role of imaging in early recurrent prostate cancer
PJL De Visschere, C Standaert, JJ Fütterer… - European urology …, 2019 - Elsevier
Context In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA)
level is a first sign of relapse, but imaging is needed to determine the localization of the …
level is a first sign of relapse, but imaging is needed to determine the localization of the …
[HTML][HTML] PSMA-targeting imaging and theranostic agents—Current status and future perspective
In the past two decades, extensive efforts have been made to develop agents targeting
prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To …
prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To …
Prostate-specific membrane antigen ligands for imaging and therapy
The prostate-specific membrane antigen (PSMA) is highly expressed on most prostate
cancer (PC) cells. Therefore, the targeting of PSMA has become increasingly important over …
cancer (PC) cells. Therefore, the targeting of PSMA has become increasingly important over …